Journal Information
Most often read
2987
Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cellsShuguang Pan, Ying Hu, Lang Gan, Jiejuan Lai, Ping Zheng, YuJun Zhang, Ling Shuai, Yan Jiang, ... Yu He
Ann Hepatol. 2024;29:101279
2987
Full text access
2573
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysisShudi Li, Fei Duan, Suling Li, Baoping Lu
Ann Hepatol. 2024;29:101174
2573
Full text access
1895
From NAFLD to MASLD: When metabolic comorbidity mattersShan Hong, Lei Sun, Yiwei Hao, Ping Li, Yuling Zhou, Xiuxia Liang, Julong Hu, Hongshan Wei
Ann Hepatol. 2024;29:101281
1895
Full text access
819
A data-driven approach to decode metabolic dysfunction-associated steatotic liver diseaseMaria Jimenez Ramos, Timothy J. Kendall, Ignat Drozdov, Jonathan A. Fallowfield
Ann Hepatol. 2024;29:101278
819
Full text access
780
Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma careInah Marie C. Aquino, Devis Pascut
Ann Hepatol. 2024;29:101176
780
Full text access
725
The landscape of inpatient admissions for alcoholic hepatitis in the era of early liver transplantationShahana Prakash, Tomohiro Tanaka
Ann Hepatol. 2024;29:101169
725
Full text access
654
Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFTJeremy Lee, Christopher J. Byrne, Paul N. Brennan, Iain MacPherson, Eleanor Dow, John F. Dillon
Ann Hepatol. 2024;29:101280
654
Full text access
558
Performance of eight predictive models for hepatocellular carcinoma recurrence after liver transplantation: A comparative studyAjacio Bandeira de Mello Brandão, Santiago Rodriguez, Cláudio Augusto Marroni, Alfeu de Medeiros Fleck Junior, Matheus V. Fernandes, Marcos Mucenic
Ann Hepatol. 2024;29:101184
558
Full text access
487
Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortalityHui Han, Qingtao Yu, Nina Qin, Bin Song, Yan Meng, Zuojing Feng, Zhaoping Li, Liyong Chen
Ann Hepatol. 2024;29:101177
487
Full text access
473
TCD assessment in fulminant hepatic failure: Improvements in cerebral autoregulation after liver transplantationFernando M Paschoal-Jr, Ricardo C Nogueira, Karla de Almeida Lins Ronconi, Marcelo de Lima Oliveira, Kelson James Almeida, Ivana Schmidtbauer Rocha, Eric Homero Albuquerque Paschoal, Joelma Karin Sagica Fernandes Paschoal, ... Edson Bor-Seng-Shu
Ann Hepatol. 2024;29:101167
473
Full text access
422
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agentsAndrea del Carmen Maldonado-Rojas, Julia María Zuarth-Vázquez, Misael Uribe, Varenka J Barbero-Becerra
Ann Hepatol. 2024;29:101182
422
Full text access
372
A practical approach to the endoscopic management of biliary strictures after liver transplantationAlex Bofill, Andrés Cárdenas
Ann Hepatol. 2024;29:101186
372
Full text access
255
MiR-326 sponges TET2 triggering imbalance of Th17/Treg differentiation to exacerbate pyroptosis of hepatocytes in concanavalin A-induced autoimmune hepatitisGenglin Zhang, Sensen Wu, Guangtao Xia
Ann Hepatol. 2024;29:101183
255
Full text access
221
Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and EuropeansSiyu Fu, Dhamina Karim, Jhon Prieto, Domingo Balderramo, Javier Diaz Ferrer, Angelo Z. Mattos, Marco Arrese, Enrique Carrera, ... Andre Boonstra
Ann Hepatol. 2024;29:101181
221
Full text access
194
The importance of fundamental pharmacology in fighting liver diseasesEduardo E. Vargas-Pozada, Erika Ramos-Tovar, Pablo Muriel
Ann Hepatol. 2024;29:101286
194
Full text access